Literature DB >> 33559195

A predictive model using left atrial function and B-type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation.

Zhenni Yang1, Min Xu1,2, Chuxu Zhang3, Huannian Liu4, Xiaoliang Shao5, Yuetao Wang5, Ling Yang1, Junhua Yang2.   

Abstract

AIM: A predictive model using left atrial function indexes obtained by real-time three-dimensional echocardiography (RT-3DE) and the blood B-type natriuretic peptide (BNP) level was constructed, and its value in predicting recurrence in patients with early persistent atrial fibrillation (AF) after radiofrequency ablation was explored.
METHODS: A total of 228 patients with early persistent AF who were scheduled to receive the first circular pulmonary vein ablation (CPVA) were enrolled. Clinical data of patients were collected: (1) The blood BNP level was measured before radiofrequency ablation; (2) RT-3DE was used to obtain the left atrial (LA) time-volume curve; (3) The clinical characteristics, BNP level and LA function parameters were compared, and logistic regression was used to construct a prediction model with combined parameters; (4) The receiver operating characteristic (ROC) curve was used to examine the diagnostic efficacy of the model.
RESULTS: (1) 215 patients with early persistent AF completed CPVA and the follow-up. After 3-6 months of follow-up, the patients were divided into sinus rhythm group (160 cases) and recurrence group (55 cases); (2) The recurrence group showed higher minimum LA volume index, diastolic ejection index, and preoperative BNP (all p ≤ .001), while the sinus rhythm group exhibited higher expansion index (PI) and left atrial appendage peak emptying velocity (p ≤ .001); (3) In univariate analysis, BNP level had the best diagnostic performance in predicting the recurrence of AF(AUC = 0.703). We constructed a model based on LA function and BNP level to predict the recurrence of persistent AF after CPVA. This combined model was better than BNP alone in predicting the recurrence of persistent AF after CPVA (AUC: 0.814 vs. 0.703, z = 2.224, p = .026).
CONCLUSION: The combined model of LA function and blood BNP level has good predictive value for the recurrence of early persistent AF after CPVA.
© 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Entities:  

Keywords:  B-type natriuretic peptide; atrial fibrillation; circular pulmonary vein ablation; echocardiography; prediction model; recurrence

Mesh:

Substances:

Year:  2021        PMID: 33559195      PMCID: PMC7943902          DOI: 10.1002/clc.23557

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   3.287


  28 in total

1.  Quality-of-life benefits of catheter ablation of persistent atrial fibrillation: a reanalysis of data from the SARA study.

Authors:  Gareth J Wynn; Moloy Das; Laura J Bonnett; Dhiraj Gupta
Journal:  Europace       Date:  2014-07-15       Impact factor: 5.214

Review 2.  Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis.

Authors:  Augustine Njoku; Munish Kannabhiran; Rishi Arora; Pratap Reddy; Rakesh Gopinathannair; Dhanunjaya Lakkireddy; Paari Dominic
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

3.  Approaches to catheter ablation for persistent atrial fibrillation.

Authors:  Atul Verma; Chen-yang Jiang; Timothy R Betts; Jian Chen; Isabel Deisenhofer; Roberto Mantovan; Laurent Macle; Carlos A Morillo; Wilhelm Haverkamp; Rukshen Weerasooriya; Jean-Paul Albenque; Stefano Nardi; Endrj Menardi; Paul Novak; Prashanthan Sanders
Journal:  N Engl J Med       Date:  2015-05-07       Impact factor: 91.245

Review 4.  Atrial fibrillation pathophysiology: implications for management.

Authors:  Yu-ki Iwasaki; Kunihiro Nishida; Takeshi Kato; Stanley Nattel
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

5.  Functional studies of left atrium and BNP in patients with paroxysmal atrial fibrillation and the prediction of recurrence after CPVA.

Authors:  M Xu; F Liu; Z-X Ge; J-M Li; X Xie; J-H Yang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-05       Impact factor: 3.507

Review 6.  Epidemiology and natural history of atrial fibrillation: clinical implications.

Authors:  S S Chugh; J L Blackshear; W K Shen; S C Hammill; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

7.  Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Authors:  Daniel B Mark; Kevin J Anstrom; Shubin Sheng; Jonathan P Piccini; Khaula N Baloch; Kristi H Monahan; Melanie R Daniels; Tristram D Bahnson; Jeanne E Poole; Yves Rosenberg; Kerry L Lee; Douglas L Packer
Journal:  JAMA       Date:  2019-04-02       Impact factor: 56.272

8.  Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation.

Authors:  Felipe Bisbal; Esther Guiu; Naiara Calvo; David Marin; Antonio Berruezo; Elena Arbelo; José Ortiz-Pérez; Teresa María de Caralt; José María Tolosana; Roger Borràs; Marta Sitges; Josep Brugada; Lluís Mont
Journal:  J Cardiovasc Electrophysiol       Date:  2013-03-14

9.  B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.

Authors:  Taku Inohara; Sunghee Kim; Karen Pieper; Rosalia G Blanco; Larry A Allen; Gregg C Fonarow; Bernard J Gersh; Michael D Ezekowitz; Peter R Kowey; James A Reiffel; Gerald V Naccarelli; Paul S Chan; Kenneth W Mahaffey; Daniel E Singer; James V Freeman; Benjamin A Steinberg; Eric D Peterson; Jonathan P Piccini
Journal:  Heart       Date:  2018-09-18       Impact factor: 5.994

10.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

View more
  3 in total

1.  A predictive model using left atrial function and B-type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation.

Authors:  Zhenni Yang; Min Xu; Chuxu Zhang; Huannian Liu; Xiaoliang Shao; Yuetao Wang; Ling Yang; Junhua Yang
Journal:  Clin Cardiol       Date:  2021-02-08       Impact factor: 3.287

2.  Left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation: A systematic review and meta-analysis.

Authors:  Pengfei Chen; Yujiao Shi; Jianqing Ju; Deng Pan; Lina Miao; Xiaolin Guo; Zhuhong Chen; Jianpeng Du
Journal:  Front Cardiovasc Med       Date:  2022-09-06

Review 3.  Assessment of Left Atrial Structure and Function by Echocardiography in Atrial Fibrillation.

Authors:  Mengmeng Ji; Lin He; Lang Gao; Yixia Lin; Mingxing Xie; Yuman Li
Journal:  Diagnostics (Basel)       Date:  2022-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.